Forbes’ John Graham knows how to write a click-bait headline, “Donald Trump on Drugs.”
Graham reviews the accuracy and implications of Donald Trump’s campaign promise to lower prices by adopting drug importation. If you’re looking for an explanation of drug importation, we linked to Douglas Holtz-Eakin’s Huffington Post article in yesterday’s Daily Rise on the competing definitions for drug importation and what it means for patients.
The GOP presidential frontrunner recently said, “Remove barriers to entry into free markets for drug providers that offer safe, reliable and cheaper products… Allowing consumers access to imported, safe and dependable drugs from overseas will bring more options to consumers.”
Graham doesn’t approve of the Donald’s spin, writing, “A more wrong-headed notion of free trade would be hard to imagine.”
For all our friends in and around Sacramento, join us on April 5th for an in-depth panel discussion, “Right Patient, Right Treatment, Right Now.”
Patients Rising Policy Director Jonathan Wilcox will moderate a conversation about the real world challenges and barriers patients are facing in accessing the medicines we need.
We’re very pleased that State Assembly Member Bill Brough will be there to share news on the bi-partisan passing of important Step Therapy legislation in California.
Date: Tuesday, April 5, 2016
Time: 11:30 AM to 1:00 PM (PDT)
If you live in Sacramento, register to join us for a lively discussion and lunch. We hope to see you there!
In today’s Advocate Survivor Voice feature, we shine the spotlight on Jennifer M. Hinkel, a partner at McGivney Global Advisors. The health economist and cancer survivor founded Resilience Racing, the first cancer survivor sailing team.
We’re featuring her latest post on LinkedIn and Medium which reveals the problems with Medicare’s February 2016 announcement that it will “create a ‘demo project’ that can randomize how cancer doctors are paid depending on what ZIP code they are in.”
“If this demo project goes through, doctors in certain ZIP codes are likely to receive massive cuts to the payments they get for providing cancer care,” she explains. “As a result, where patients get treatment might start to dictate how much treatment they get, or even whether they get certain medications at all. Medicare claims this will lower costs.”
Read Hinkel’s entire piece to learn more about this “capricious gamble with the health of cancer patients.”
Morning Consult’s Mary Ellen McIntire checks up on President Obama’s Supreme Court nominee Merrick Garland and his record on health care.
As chief justice of the U.S. Court of Appeals for the District of Columbia, Garland sat on a three-judge panel that decided how Health and Human Services determines Medicare payments. The case, recapped by McIntire, was Northeast Hospital Corporation v. Sebelius.
“The Medicare statute provides a very specific, carefully reticulated formula for calculating supplemental payments to hospitals that serve a disproportionate number of low-income Medicare patients,” reads the decision supported by Garland. “By counting patients enrolled in Part C plans as “entitled to benefits under part A” for specific patient days, HHS misapplied the statute and undercompensated Beverly Hospital.”